LATEST NEWS

BRAZIL’s INMETRO proposing new model

Date: 07/19/2019

INMETRO has issued a public consultation regarding the proposal for what they are calling a “New regulatory model for INMETRO”. The main goal, according to INMETRO’s director Gustavo Kuster, is to make Brazilian market safer for society and citizens and to create a less bureaucratic and more simple system. The action is a part of INMETRO’s new strategy aiming to simplify the process by creating rules that cover a wide range of products, following the example of the European Union.

Also according to director Gustavo Kuster, manufacturers will have more responsibilities as well as freedom to market their products. “It takes us up to seven years to implement new measures nowadays. The solution is to rethink the entire model. Our strategy is to simplify, that’s why it is important that the community takes part in the public audiences that will be open aiming to narrow the existent proposals and to make the simplest regulation process possible. This is one of the new government’s goals.”

Making it less bureaucratic helps to increase competitiveness among products (either locally manufactured or imported) marketed in Brazil. It is vital to help companies by making INMETRO’s certification process faster – he adds.

“We need a simpler and less prescriptive regulation, that allows innovation” – highlights the director.
Currently, INMETRO works with a framework that covers 684 items, including a wide range of medical devices, which represents only 10% of the products marketed in Brazil. Kruse points out that we need to modernize our present regulation rules by creating basic general principles that will ensure the safety and quality of all products. The goal is to cover 100% of the products traded in the national market.

All citizens and companies will have 60 days to answer seven questions that will contribute to the first step into the changing process. In order to participate and make suggestions, please check INMETRO’s website.

INMETRO is concerned about making the future transition to the new model as smooth as possible for manufacturers, certification bodies and the society. In due course, changes regarding all the regulated products and categories will be scheduled considering the proper time for everyone to adjust. We believe the current public consultation indicates INMETRO’s intentions of building this project with the participation of the parties involved.

DOMO Salute’s team will take active part in the process and keep you informed on the following projects and changes regarding INMETRO’s certification.
Follow us on LinkedIn to get an update on the top news regarding the Brazilian regulatory system.

DOMO Salute Team

Check INMETRO’s proposal (Portuguese)
Watch Gustavo Kuster’s invitation to take part on the public consultation (Portuguese)
Access to the public consultation (Portuguese)

MORE NEWS

07/18/2024
  From June 24 to 28, ANVISA participated in the MDSAP Forum and Regulatory Authority Council (RAC) meeting in Essen, Germany. The event gathered representatives from 27 countries, including regulatory authorities, MDSAP auditing organizations, and industry representatives, with notable attendance from Brazilian associations ABIMED and [...]
07/02/2024
  In force since January 2022, RDC 591/2021, which provides for the Unique Device Identification (UDI) system, was amended by ANVISA just days before the deadline for attributing and affixing UDI to risk class IV devices. The amendment was published in RDC 884/2024 on June 1, 2024, and is already in force. According to ANVISA,... Leia [...]
04/12/2024
Marking a significant advancement in regulatory reliance mechanisms, the National Health Surveillance Agency (ANVISA) published Normative Instruction (IN) 290/2024, on April 8, 2024. This normative introduces an optimized procedure for evaluating and deciding on registration petitions for medical devices previously regulated in recognized [...]
03/22/2024
Important Regulatory Update for Manufacturers under MDSAP in Brazil Today, ANVISA has announced a significant regulatory development with the publication of Resolution RDC 850/2024. This regulation brings forth a crucial amendment concerning the validity period of the Brazilian Good Manufacturing Practices (BGMP) Certificate for manufacturers [...]
01/05/2024
Collegiate Board Resolution (RDC) 837/2023, published by ANVISA on December 15th, 2023, brings updates to the rules regarding clinical investigations with medical devices performed in Brazil. Effective immediately from the publication, this resolution aligns Brazilian practices with international standards, providing clearer guidelines for [...]
12/13/2023
On 11 of December 2023, ANVISA published Collegiate Board Resolution – RDC 830/2023, addressing risk classification, registration procedures, as well as labeling requirements and instructions for use of in vitro diagnostic medical devices (IVDs) in Brazil. The new RDC, effective from June 1, 2024, is a comprehensive revision that consolidates [...]
11/28/2023
Public Consultation No. 1.208 will be open to receive contributions until December 9th. In the dynamic landscape of medical device regulations in Brazil, obtaining the Brazilian Good Manufacturing Practices (BGMP) certification is a mandatory request for manufacturers of Class III and Class IV devices seeking Registro. In a recent move towards [...]
03/01/2023
  Starting today – March 1st 2023 – the new Resolution RDC nº 751/2022  comes into force. The Resolution provides for risk classification, Notification and Registro processes, and the requirements for medical devices’ labeling and instructions for use. In order to meet the new requirements and procedures, ANVISA has already [...]
09/22/2022
The Collegiate Board Resolution – RDC 751/2022 was published on the 21st of September 2022, which provides for risk classification, Notification and Registro processes, and the requirements for medical devices’ labeling and instructions for use. The new RDC consolidates the risk classification and regularization regimes for all risk [...]